Visit the TerrAscend Investor Dashboard and stay up to date with data-driven, fact based due diligence for active traders and investors.
TORONTO, Feb. 5, 2018 /CNW/ – TerrAscend Corp. (CSE: TER) (“TerrAscend” or the “Company”) is pleased to announce that its wholly-owned subsidiary, Solace Health Inc. (“Solace”), has been granted an oil production license by Health Canada pursuant to the Access to Cannabis for Medical Purposes Regulations. This important milestone will enable Solace to commence the commercial production and formulation of cannabis-derived oils for its consumers.
Our team’s efforts and experience have enabled Solace to exceed industry standards in progressing through Health Canada’s licensing processes. The granting of our oil production license is an especially exciting milestone for the Company as we continue our efforts towards providing high quality and consistently dosed cannabis products to support the health and wellness of our consumers.
Michael Nashat, TerrAscend’s President and CEO
Solace will commence the production of cannabis oils at its Mississauga, Ontario facility to be sold both in Canada and in global markets. Solace’s focus on developing quality, non-combustible cannabis products for consumers will be enhanced by the Company’s pharmaceutical formulations experience.
TerrAscend is a Canadian cannabis company that strives to create and deliver quality products and services that meet the evolving needs of Consumers. The Company provides support to medical consumers through its wholly-owned subsidiaries, Solace Health Inc., a licensed producer of medical cannabis under the Access to Cannabis for Medical Purposes Regulations and Terra Health Network Inc., a clinical support program and education platform led by healthcare professionals.
Please visit www.TerrAscend.com for more information about the Company.
The most reliable, fact-based information on TerrAscend found only on its Investor Dashboard.
Before this cannabis stock news is here, it’s published to subscribers on 420 Investor.